Insider Transactions Reported by 9 Insiders of Axsome Therapeutics, Inc.

Symbol
AXSM on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Axsome Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
HERRIOT TABUTEAU Chief Executive Officer, Director, 10%+ Owner $1,034,241,574 -$46,244,203 -4.3% 02 Dec 2025
Mark Coleman Director $50,320,015 -$905,382 -1.8% 08 Sep 2025
Nick Pizzie Chief Financial Officer $8,063,558 -$1,951,530 -19% 21 Feb 2025
ROGER JEFFS Director $7,117,764 -$13,373,843 -65% 02 Sep 2025
Mark Jacobson Chief Operating Officer $2,822,986 -$13,394,363 -83% 22 Sep 2025
R. Murdock General Counsel $2,111,540 -$3,647,497 -63% 20 Jun 2025
Ari Maizel Chief Commercial Officer $2,028,964 21 Feb 2025
Mark E. Saad Director $1,700,925 -$7,348,483 -81% 31 Dec 2025
Susan Mahony Director $4,592 06 Jun 2025

Recent Insider Transactions by Companies or Individuals for Axsome Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.